You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to August 2024

AbstractFullPdf
Jun 20174401
Jul 20176207
Aug 20174809
Sep 201778021
Oct 20173403
Nov 201738012
Dec 20173205
Jan 201854010
Feb 20185103
Mar 20187603
Apr 201860013
May 20187204
Jun 20181601
Jul 20181401
Aug 20182003
Sep 2018202
Oct 20183608
Nov 20181206
Dec 20181003
Jan 2019601
Feb 20191804
Mar 20191203
Apr 2019603
May 2019304
Jun 2019403
Jul 2019405
Aug 2019001
Sep 2019001
Oct 2019401
Nov 2019002
Dec 2019001
Jan 2020200
Feb 2020001
Mar 2020002
Apr 2020202
Jun 2020602
Jul 20201402
Aug 2020403
Sep 20201200
Oct 2020401
Nov 2020201
Dec 2020801
Jan 2021001
Mar 2021202
Apr 2021204
May 2021001
Jul 2021003
Aug 2021001
Sep 2021003
Oct 202111017
Nov 20214014
Dec 2021801
Jan 2022401
Feb 2022801
Mar 2022503
May 20221206
Jun 20221204
Jul 20221000
Aug 20221402
Sep 2022607
Oct 20221603
Nov 2022400
Dec 2022802
Jan 2023601
Feb 2023200
Mar 20231000
May 2023002
Jun 2023402
Jul 2023706
Aug 2023805
Oct 2023502
Nov 2023203
Dec 20231000
Jan 20241600
Feb 2024402
Mar 2024202
Apr 2024609
May 2024500
Jun 20241001
Jul 2024202
Aug 2024601
Total11010273